People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tissue Genesis Inc | — | Biotechnology | Series A | $20.9M | $18.1M | 2011 |
Jeffrey C Watanabe at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey C Watanabe on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bradley C. Perkins | 1 | 1 |
| Michael C. Ruley | 1 | 1 |
| Paul C. Kosnik | 1 | 1 |
| Anton C. Krucky | 1 | 1 |
| Robert C. Hiam | 1 | 1 |
| Jeffery C. Watanabe | 1 | 1 |
| Thomas C. Cannon | 1 | 1 |
| William C. Wiesmann | 1 | 1 |
| Jeff C. Watanabe | 1 | 1 |
| Robert Hiam | 1 | 1 |
| Hiam Robert | 1 | 1 |
| Lawrence C. Rodriguez | 1 | 1 |
| Timothy C. Sarhatt | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.